Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • Israel
  • USA
  • Canada
Investment stages
  • Seed
Industries
  • Fintech
  • Pharma
  • Biotechnology
  • Health Tech
  • Medical Devices
About
MPM BioImpact is building companies to transform patient outcomes.
Min check size
$1M
Max check size
$10M
Fund size
NPS

Investment Thesis

They create and invest in biotech companies with innovative technologies that are developing lifesaving drugs for patients. They invest in both private and public companies, providing a unique longitudinal view of drug development across the industry.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Bringing a wealth of experience in private equity, the fund manager has successfully executed over 50 deals across various sectors, including technology, healthcare, and consumer products. Primarily focused on North America and Europe, they adopt a thematic investment approach, emphasizing data-driven decision-making. With a strong track record of notable exits, they prioritize growth-stage investments, ensuring alignment with operator-first strategies that enhance operational efficiencies. Their strategic style is characterized by a deep understanding of market dynamics and a commitment to value creation.

MPM BioImpact Contacts Information

Primary contact

Secondary contact

Team

William Greene

Todd Link

Todd Foley

Steven Peter

Sarah

Ryan Hersey

Patrick A. Baeuerle

Luke Evnin

Luke Evnin

Liz Doherty

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp